Citation: A. Hsu et al., RITONAVIR - CLINICAL PHARMACOKINETICS AND INTERACTIONS WITH OTHER ANTI-HIV AGENTS, Clinical pharmacokinetics, 35(4), 1998, pp. 275-291
Authors:
FRYE RF
BERTZ RJ
GRANNEMAN GR
LAUVA I
LAMM J
DENNIS S
VALDES J
Citation: Rf. Frye et al., EFFECT OF RITONAVIR ON CYP1A2, 2C19, AND 2E1 ACTIVITIES IN-VIVO, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 44-44
Citation: Rj. Bertz et Gr. Granneman, USE OF IN-VITRO AND IN-VIVO DATA TO ESTIMATE THE LIKELIHOOD OF METABOLIC PHARMACOKINETIC INTERACTIONS, Clinical pharmacokinetics, 32(3), 1997, pp. 210-258
Authors:
BERTZ RJ
KROBOTH PD
KROBOTH FJ
REYNOLDS IJ
SALEK F
WRIGHT CE
SMITH RB
Citation: Rj. Bertz et al., ALPRAZOLAM IN YOUNG AND ELDERLY MEN - SENSITIVITY AND TOLERANCE TO PSYCHOMOTOR, SEDATIVE AND MEMORY EFFECTS, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1317-1329
Citation: Pd. Kroboth et al., TRIAZOLAM PHARMACOKINETICS AFTER INTRAVENOUS, ORAL, AND SUBLINGUAL ADMINISTRATION, Journal of clinical psychopharmacology, 15(4), 1995, pp. 259-262
Citation: Rj. Bertz et al., EFFECT OF NEUROACTIVE STEROIDS ON [H-3] FLUMAZENIL BINDING TO THE GABA(A) RECEPTOR COMPLEX IN-VITRO, Neuropharmacology, 34(9), 1995, pp. 1169-1175
Authors:
BERTZ RJ
SALEK FS
KROBOTH FJ
REYNOLDS IJ
WRIGHT CE
SMITH RB
KROBOTH PD
Citation: Rj. Bertz et al., DOES AGE INFLUENCE THE DEVELOPMENT OF TOLERANCE TO ALPRAZOLAM, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 146-146
Authors:
BERTZ RJ
REYNOLDS IJ
KROBOTH FJ
WRIGHT CE
SMITH RB
KROBOTH PD
Citation: Rj. Bertz et al., SENSITIVITY OF YOUNG AND ELDERLY MEN TO THE PSYCHOMOTOR EFFECTS OF ALPRAZOLAM, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 135-135